Mitsui Chemicals Group has reported a mixed set of results for fiscal 2025 as global geopolitical tensions, trade uncertainty, and softer chemical demand weighed on performance despite pockets of growth in healthcare and ICT businesses.
“Economic recovery continued moderately worldwide,” the company noted, but warned that “the pace of recovery in some countries and regions has slowed amid weak demand and U.S. trade policies.”
It also highlighted rising geopolitical risk, stating that “the instability in the Middle East, driven by military conflicts between the United States and Iran, has increased uncertainty regarding energy supplies and international logistics.”
Japan’s economy showed steady improvement, with “the improvement of employment and income environment,” but the company flagged that “uncertainty increased due to the impact of U.S. trade policies and the international situation.”
Within the chemical industry, conditions remained difficult as “domestic naphtha cracker operating rates remained low due to slowing demand for downstream products,” while “instability in the Middle East has heightened uncertainty surrounding energy supplies and raw material procurement.”
Against this backdrop, Mitsui Chemicals said it continues to pursue its long-term transformation strategy under “VISION 2030,” focusing on ESG-driven growth and innovation in materials.
In Life & Healthcare Solutions, the company is doubling down on high-value healthcare and medical assets. It highlighted the relocation of SDC Technologies in the United States, which “aims to significantly strengthen SDC’s research and development and manufacturing capabilities.”
It also moved to expand into genomics, completing a takeover of DNA Chip Research, which now operates as a wholly owned subsidiary. The company said the move supports its ambition to develop the medical sector as a third pillar alongside life care and wellness.
In Mobility Solutions, shifting automotive demand trends—particularly electrification and lightweighting—continue to reshape the business. Mitsui Chemicals is strengthening global integration across regions and expanding partnerships, including a marketing collaboration with Polyplastics Co., Ltd. for engineering plastics “known for their high heat resistance and other advanced performance characteristics.”
Despite strategic progress, earnings were under strain.
“Operating income before special items was 100.0 billion yen, a decrease of 1.0 billion yen, or 0.9%, year on year,” mainly due to weaker inventory revaluation gains linked to falling raw material prices such as naphtha.
“Operating income was 73.8 billion yen, a decrease of 4.5 billion yen, or 5.8%, year on year,” reflecting both weaker underlying performance and impairment losses in Chinese phenol-related investments.
The company added that “financial income/expenses improved 1.5 billion yen year on year to a 5.2 billion yen loss.”
As a result, “income before income taxes amounted to 68.6 billion yen, a decrease of 3.0 billion yen, or 4.2%, year on year.”
However, net profit rose modestly: “Net income attributable to owners of the parent… was 34.4 billion yen, an increase of 2.2 billion yen, or 6.6%, year on year.” Basic earnings per share stood at 91.62 yen.
Performance varied sharply across divisions.
Life & Healthcare Solutions delivered steady growth, with “sales revenue increased 7.4 billion yen… to 259.1 billion yen,” driven by vision care materials and agrochemicals.
Mobility Solutions weakened, with revenue falling due to “the transfer of the Group’s subsidiary shares” and lower polypropylene compound sales affected by “U.S. tariffs, a shortage of semiconductor supplies, and reduced production… following a fire at an aluminum plant in North America.”
ICT Solutions was a bright spot, with “operating income before special items increased 10.2 billion yen to 36.9 billion yen,” supported by “healthy sales in semiconductor & optical materials.”
In contrast, Basic & Green Materials remained under pressure, posting an “18.4 billion yen loss,” driven by “worsened inventory revaluation gain and loss resulting from the falling raw material prices, such as naphtha.”
Despite earnings pressure, the company maintained financial stability.
Total assets stood at 2,151.7 billion yen, while total equity rose to 988.8 billion yen. The equity ratio improved to 40.2%, and the net debt-equity ratio improved to 0.70. Cash and cash equivalents increased to 183.1 billion yen.
Looking ahead, Mitsui Chemicals warned that uncertainty remains elevated.
“In fiscal 2026, the global economy continues to face risks related to energy supply and international logistics due to the instability in the Middle East, driven by military conflicts between the United States and Iran, and the outlook remains uncertain.”
